Evidence map›Paper›PMID 31823333›Full record

ArticleJournal of medical toxicology : official journal of the American College of Medical Toxicology2020

Single-Agent Bupropion Exposures: Clinical Characteristics and an Atypical Cause of Serotonin Toxicity.

Brian Murray, Joseph Carpenter, Camille Dunkley, Tim P Moran, Emily A Kiernan, Tony Rianprakaisang, Waleed S Alsukaiti, Diane P Calello, Ziad Kazzi, Toxicology Investigators Consortium (ToxIC)

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Identification of a binding site for bupropion inbioRxiv : the preprint server for biology · 2023
    Article
  5. Review
  6. Review
  7. Article
  8. In Response to Borgsteede et al. About Bupropion and Serotonin Toxicity.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2020
    Article
  9. No Causal Relation Between Bupropion in Therapeutic Dose and Serotonin Toxicity.Journal of medical toxicology : official journal of the American College of Medical Toxicology · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Brian MurrayEmory University School of Medicine, Atlanta, GA, USA. bpmurra@emory.edu.ORCID 0000-0002-7950-6762
Joseph CarpenterEmory University School of Medicine, Atlanta, GA, USA.
Camille DunkleyEmory University School of Medicine, Atlanta, GA, USA.
Tim P MoranEmory University School of Medicine, Atlanta, GA, USA.
Emily A KiernanEmory University School of Medicine, Atlanta, GA, USA.
Tony RianprakaisangOregon Health and Science University, Portland, OR, USA.
Waleed S AlsukaitiGeorgia Poison Center, Atlanta, GA, USA.
Diane P CalelloRutgers New Jersey Medical School, Newark, NJ, USA.
Ziad KazziEmory University School of Medicine, Atlanta, GA, USA.
Toxicology Investigators Consortium (ToxIC)
Emory University · USOregon Health & Science University · USRutgers, The State University of New Jersey · USWashington Poison Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionBupropion is the only Food and Drug Administration-approved synthetic cathinone. It increases the release of norepinephrine in the locus coeruleus and dorsal raphe nucleus, causing an increase in the frequency of serotonergic neuron firing. The diagnosis of serotonin toxicity (ST) from bupropion poisoning is controversial due to the lack of direct serotonergic activity. Nonetheless, there is one documented report of ST after single-agent bupropion overdose and multiple reports describing polypharmacy overdoses where bupropion may have contributed to ST.

methodsThis is a retrospective analysis of data collected by the Toxicology Investigators Consortium (ToxIC), a prospective multi-center toxico-surveillance and research network registry, from 2014 to 2017. Cases were identified if ST was a clinical effect and bupropion was the single agent listed. Data is presented descriptively.

resultsOf the 266 recorded single bupropion overdoses, the most common symptoms were seizures (47.1%), tachycardia (greater than 140 bpm) (33.9%), agitation (31.7%), toxic psychosis (20.4%), and myoclonus/tremor/hyperreflexia (19%). Benzodiazepines were the most common therapy (69.2%). Thirteen patients (5.9%) were diagnosed with ST by a medical toxicologist.

conclusionBupropion overdose is primarily associated with seizures, tachycardia, and agitation; bupropion may be an atypical cause of serotonin toxicity.

Indexed as

AdolescentAdultAntidepressive Agents, Second-GenerationBupropionCardiotoxicityDyskinesia, Drug-InducedFemaleHumansMalePrevalenceRegistriesRetrospective StudiesSeizuresSerotonin SyndromeTachycardiaUnited StatesAntidepressive Agents, Second-GenerationBupropionAbuseBupropionCharacteristicsSerotonin syndromeSingle-agent

Identifiers

PMID31823333
PMCPMC6942117
OpenAlexW2995908397

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.